ResMed Inc (RMD)
Return on assets (ROA)
| Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 1,400,720 | 1,020,950 | 897,556 | 779,437 | 474,505 |
| Total assets | US$ in thousands | 8,174,390 | 6,872,390 | 6,751,710 | 5,095,850 | 4,728,120 |
| ROA | 17.14% | 14.86% | 13.29% | 15.30% | 10.04% |
June 30, 2025 calculation
ROA = Net income ÷ Total assets
= $1,400,720K ÷ $8,174,390K
= 17.14%
The analysis of ResMed Inc.'s return on assets (ROA) over the indicated period reveals several noteworthy trends. As of June 30, 2021, the company's ROA stood at 10.04%, reflecting its profitability relative to its total assets during that year. This figure increased significantly by June 30, 2022, reaching 15.30%, representing a substantial improvement in how efficiently the company utilizes its assets to generate net income.
However, this upward trajectory experienced a slight moderation by June 30, 2023, with ROA declining to 13.29%. Despite this decrease, the ROA remained well above the 2021 level, indicating continued effective asset utilization with some possible influence from market or operational factors during that period.
The positive momentum resumed, with the ROA rising again to 14.86% as of June 30, 2024. The most recent data for June 30, 2025, shows a further increase to 17.14%, marking a new peak and suggesting an ongoing improvement in asset efficiency and profitability.
Overall, the trend from 2021 through 2025 demonstrates that ResMed Inc. has experienced substantial growth in its ability to generate profit from its assets, with a notable acceleration in recent years leading to an elevated ROA. This pattern may reflect enhancements in operational efficiency, product profitability, or strategic initiatives that have bolstered the company's asset utilization.
Peer comparison
Jun 30, 2025